Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lutterotti

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|September 25, 2023
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosisBenjamin Vlad, Ina Reichen, Stephan Neidhart, et al.
BMJ Neurology Open|February 2, 2023
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)Lutz Achtnichts, Chiara Zecca, Oliver Findling, et al.
Antibodies (Basel, Switzerland)|December 27, 2024
Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female SexBenjamin Vlad, Marc Hilty, Stephan Neidhart, et al.
Fluids and Barriers of the CNS|October 28, 2011
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosisRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 18, 2018
Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic NeuritisIlijas Jelcic, James V M Hanson, Sebastian Lukas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2017
Change of olfactory function as a marker of inflammatory activity and disability progression in MSGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Journal of Neuroimmunology|August 27, 2010
Natalizumab treatment reduces endothelial activity in MS patientsAlban Millonig, Harald Hegen, Franziska Di Pauli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2024
Intrathecal immune reactivity against Measles-, Rubella-, and Varicella Zoster viruses is associated with cerebrospinal fluid inflammation in multiple sclerosisBenjamin Vlad, Stephan Neidhart, Marc Hilty, et al.
Science Translational Medicine|October 12, 2018
GDP-l-fucose synthase is a CD4<sup>+</sup> T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosisRaquel Planas, Radleigh Santos, Paula Tomas-Ojer, et al.
Plos One|May 14, 2010
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis opticaSimone Mader, Andreas Lutterotti, Franziska Di Pauli, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|September 25, 2023
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosisBenjamin Vlad, Ina Reichen, Stephan Neidhart, et al.
BMJ Neurology Open|February 2, 2023
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)Lutz Achtnichts, Chiara Zecca, Oliver Findling, et al.
Antibodies (Basel, Switzerland)|December 27, 2024
Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female SexBenjamin Vlad, Marc Hilty, Stephan Neidhart, et al.
Fluids and Barriers of the CNS|October 28, 2011
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosisRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 18, 2018
Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic NeuritisIlijas Jelcic, James V M Hanson, Sebastian Lukas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2017
Change of olfactory function as a marker of inflammatory activity and disability progression in MSGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Journal of Neuroimmunology|August 27, 2010
Natalizumab treatment reduces endothelial activity in MS patientsAlban Millonig, Harald Hegen, Franziska Di Pauli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2024
Intrathecal immune reactivity against Measles-, Rubella-, and Varicella Zoster viruses is associated with cerebrospinal fluid inflammation in multiple sclerosisBenjamin Vlad, Stephan Neidhart, Marc Hilty, et al.
Science Translational Medicine|October 12, 2018
GDP-l-fucose synthase is a CD4<sup>+</sup> T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosisRaquel Planas, Radleigh Santos, Paula Tomas-Ojer, et al.
Plos One|May 14, 2010
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis opticaSimone Mader, Andreas Lutterotti, Franziska Di Pauli, et al.
Pageof 7